Our findings identify and characterize a novel mechanism of oxaliplatin uptake mediated by LAT3 in CRC cells, which appears to be independent of its normal amino acid transport function and can regulate sensitivity to oxaliplatin by accumulation of DNA-Pt adducts and DNA damage. The gene discussed is SLC43A1; the disease is colorectal carcinoma.